Cannara Biotech Inc (LOVE.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 02-2026 | 11-2025 | 08-2025 | 05-2025 | 02-2025 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,309 | 1,581 | 2,232 | 1,265 | 1,635 |
| Income taxes - deferred | 1,157 | 1,001 | 1,227 | 1,650 | 1,415 |
| Accounts receivable | 2,744 | -1,092 | 390 | 1,621 | -2,527 |
| Accounts payable and accrued liabilities | -1,018 | 1,922 | -2,075 | 1,699 | -142 |
| Other Working Capital | -2,700 | -163 | -4,153 | 6,533 | -9,017 |
| Other Operating Activity | 1,456 | 4,713 | 5,206 | 1,134 | 6,086 |
| Operating Cash Flow | $2,948 | $7,961 | $2,827 | $13,902 | $-2,550 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,095 | -4,618 | -1,326 | -2,191 | -1,469 |
| Other Investing Activity | 88 | 60 | 83 | 54 | 72 |
| Investing Cash Flow | $-3,006 | $-4,559 | $-1,243 | $-2,136 | $-1,397 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | -1 | 0 | N/A |
| Debt Repayment | -659 | -654 | -654 | -1,665 | -162 |
| Common Stock Issued | 6,300 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -198 | -591 | -976 | -748 | -1,097 |
| Financing Cash Flow | $5,444 | $-1,245 | $-1,631 | $-2,413 | $-1,259 |
| Beginning Cash Position | 16,517 | 14,360 | 14,408 | 5,055 | 10,261 |
| End Cash Position | 21,902 | 16,517 | 14,360 | 14,408 | 5,055 |
| Net Cash Flow | $5,385 | $2,157 | $-48 | $9,352 | $-5,206 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,948 | 7,961 | 2,827 | 13,902 | -2,550 |
| Capital Expenditure | -3,235 | -4,618 | -1,466 | -2,207 | -1,469 |
| Free Cash Flow | -286 | 3,343 | 1,361 | 11,695 | -4,019 |